The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index; 39 of the 51 sources its claims cite were checked for support.
Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review
Open accessAbstract
Background : Chronic obstructive pulmonary disease (COPD) is a major contributor to morbidity, mortality, and healthcare utilization worldwide. In Gulf Cooperation Council (GCC) countries, the evidence on COPD-related acute-care utilization and medication adherence remains fragmented; hence, this scoping review aimed to map and characterize the available evidence. Methods : This scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist. PubMed/MEDLINE, Embase, Scopus, Cochrane Library, and Google Scholar were searched from inception to 22 May 2026. Eligible studies reported COPD-related acute-care utilization and/or medication adherence outcomes in GCC countries. Two reviewers independently screened the studies, extracted the data, and assessed the methodological quality using Joanna Briggs Institute appraisal tools. The findings were synthesized narratively. Results : The search identified 328 records, of which 15 studies were included. Most originated from Saudi Arabia, with retrospective cohort and cross-sectional designs predominating. A higher comorbidity burden, obesity, respiratory infection, and disease severity were associated with increased acute-care utilization. Poor medication adherence was associated with increased emergency department visits and hospitalizations. The emerging evidence highlights eosinophilic and obesity-associated COPD phenotypes as potential contributors…
Overview
CoChat Summary
TL;DR
This PRISMA-ScR scoping review mapped 15 studies on COPD-related acute-care utilization and medication adherence in Gulf Cooperation Council countries, finding substantial hospitalization, ICU, readmission, and adherence burdens alongside geographically uneven evidence. The authors conclude the evidence base is limited, heterogeneous, and insufficient for robust regional benchmarking or causal inference.
Key findings
- The search identified 328 records and included 15 studies; most originated from Saudi Arabia, with retrospective cohort and cross-sectional designs predominating.
- Acute-care burden was substantial: median ICU LOS was 9 days in one Saudi ICU cohort; median hospital LOS was 5 days in a tertiary Saudi population, with male sex associated with +1.30 days and cancer/malignancy with +2.73 days; mean hospital LOS in Kuwait was 10.3 days. ICU mortality was 6% and hospital mortality 11% in one Saudi ICU-managed exacerbation cohort; another UAE multicenter cohort reported 24.4% mortality and a 90-day readmission rate of 35.9% (184/512).
- ED utilization was high: 44.6–57.5% of COPD patients in Saudi Arabia used ED services within one year, and 18.7–33.1% required hospitalization after ED presentation; lower medication adherence was significantly associated with increased ED visits.
- Low medication adherence prevalence was 64.2% in the ADCARE study, with living in Saudi Arabia rather than Turkey a significant predictor (OR = 3.20). Eosinophilic COPD prevalence was 48.7% in Saudi Arabia, and 42.2% of AECOPD patients in Oman had elevated peripheral eosinophils, associated with more recurrent hospitalizations (median one annual readmission vs zero for non-eosinophilic patients).
Methods
- Scoping review conducted per PRISMA-ScR; PubMed/MEDLINE, Embase, Scopus, Cochrane Library, and Google Scholar were searched from inception to 22 May 2026.
- Eligibility used a Population–Concept–Context framework: adults with COPD in GCC countries, reporting acute-care utilization and/or medication adherence outcomes; observational or interventional designs were eligible, with exclusions for non-COPD focus, lack of extractable GCC-specific data, mixed respiratory populations without separable COPD outcomes, and non-primary research.
- Two reviewers independently screened, extracted data, and assessed methodological quality using Joanna Briggs Institute tools; findings were synthesized narratively by thematic domains.
Limitations
- The paper states substantial geographic disparities, with most studies from Saudi Arabia and the UAE and limited evidence from Bahrain, Qatar, Kuwait, and Oman; considerable methodological heterogeneity in exacerbation definitions and outcome reporting; many retrospective single-center studies limiting generalizability and causal inference; inconsistent reporting of confidence intervals, adjusted effect estimates, and standardized outcome measures; restriction to English-language publications; and observational designs preventing causal conclusions.
- The paper also reports that the OSF registration was post hoc, completed after the review process and updated later due to an expanded search.
- Evident from the text: JBI appraisal rated the evidence base predominantly moderate, with only two studies high quality and two low-to-moderate; common limitations included inadequate confounding control, unclear population characteristics, and potential measurement bias in self-reported adherence data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
32 Valid · 1 Not valid · 11 Not checked · 24 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“while cancer/malignancy was associated with an additional 2.73 days.”
§ Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review > 3. Results > 3.4. Acute-Care Utilization Outcomes
What the sources say
- Supportedcites [17] Alotaibi, 2025, Length of stay and comorbidity prevalence among individuals with chronic obstructive pulmonary disease in a tertiary care healthcare center in Saudi Arabia; A cross-sectional study, Medicine source
The Results report that, in the multivariate analysis, COPD patients with cancer had an expected hospital stay 2.73 days longer than patients without cancer. The Methods identify malignancy as a comorbidity analyzed, and the study was conducted at a tertiary healthcare center in Saudi Arabia. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“reporting an ICU mortality rate of 6% and a hospital mortality rate of 11% among ICU-managed exacerbation patients in Saudi Arabia.”
§ Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review > 3. Results > 3.4. Acute-Care Utilization Outcomes
What the sources say
- Supportedcites [4] Alaithan, 2012, Chronic obstructive pulmonary disease: Hospital and intensive care unit outcomes in the Kingdom of Saudi Arabia, Int. J. Chronic Obstr. Pulm. Dis. source
The Results report that, among 119 patients admitted to the ICU for COPD exacerbation, hospital mortality was 11% and ICU mortality was 6%. The Discussion likewise identifies these as the study’s mortality rates for patients admitted with respiratory failure due to COPD exacerbation. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Alshehri and Alshibani [10] reported that 44.6–57.5% of COPD patients in Saudi Arabia utilized ED services within one year”
§ Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review > 3. Results > 3.4. Acute-Care Utilization Outcomes
What the sources say
- Partly supportedcites [10] Alshehri, 2020, Impact of medication adherence on emergency department visits in patients with COPD in a single tertiary hospital in Saudi Arabia, Int. J. Chronic Obstr. Pulm. Dis. sourceExperimental — accuracy not yet measured
The Results > Outcomes section (page not provided) reports one-year ED visits for 44.6% of the high-adherence group and 57.5% of the low-adherence group. But these were patients admitted for COPD exacerbations at one Saudi hospital, not a representative sample of COPD patients across Saudi Arabia; the Discussion explicitly cautions against generalizing the results. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Moreover, in that study mortality among hospitalized exacerbation patients was 24.4%, with a 90-day readmission rate of 35.9% [16].”
§ Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review > 3. Results > 3.4. Acute-Care Utilization Outcomes
What the sources say
- Supportedcites [16] Almarshoodi, 2024, An international validation of the “DECAF score” to predict disease severity and hospital mortality in acute exacerbation of COPD in the UAE, Hosp. Pharm. source
Table 1 in Results (General Characteristics of Participants) reports 125 inpatient deaths among 512 patients admitted with acute exacerbation of COPD (24.4%). It also reports a 90-day readmission rate of 35.9%, matching the citing sentence. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Obesity-related studies conducted in Saudi Arabia also identified significant associations between obesity, ICU admission, and comorbidity burden among COPD patients [5].”
§ Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review > 3. Results > 3.4. Acute-Care Utilization Outcomes
What the sources say
- Supportedcites [5] Alqarni, 2024, Obesity prevalence and association with spirometry profiles, ICU admission, and comorbidities among patients with COPD: Retrospective study in two tertiary centres in Saudi Arabia, Int. J. Chronic Obstr. Pulm. Dis. source
The Results report that comorbidities and ICU admission were associated with overweight and obesity among COPD patients after adjustment for age, gender, and smoking. The Discussion specifies that obese patients had more comorbidities and higher ICU admission rates than normal-weight patients in this Saudi study. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
29 more claims · 16 with their cited sources checked
Create a free account to see all 68 claims and every source verdict.
- Probably not a substantial claim. 17
- The quote only partly states this claim. 1
- It may state two separate claims as one. 22
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Alqahtani, J. S., Njoku, C. M., Bereznicki, B., Wimmer, B. C., Peterson, G. M., Kinsman, L., Aldabayan, Y. S., Alrajeh, A. M., Aldhahir, A. M., Mandal, S., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0166-2019 · Cited by 149
Adherence to COPD treatment in Turkey and Saudi Arabia: Results of the ADCARE study
Kokturk, N., Polatli, M., Oguzulgen, I. K., Saleemi, S., Al Ghobain, M., Khan, J., Doble, A., Tariq, L., Aziz, F., & El Hasnaoui, A. (2018) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s150411 · Cited by 53
Polatli, M., Ben Kheder, A., Wali, S., Javed, A., Khattab, A., Mahboub, B., Iraqi, G., Nejjari, C., Taright, S., Koniski, M.-L., et al. (2012) · Respiratory Medicine · doi:10.1016/s0954-6111(12)70016-1 · Cited by 45
Alaithan, A., Memon, Rehmani, Qurashi, & Salam (2012) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s37611 · Cited by 43
(2009) · PubMed · Cited by 23
Onadeko, B. O., Khadadah, M., Abdella, N., Mukhtar, M., Mourou, M., Qurtom, M., Samad, M., & Al-Shayeb, A. (2005) · Medical Principles and Practice · doi:10.1159/000081921 · Cited by 16
Alqarni, A., Badr, O., Aldhahir, A., Alqahtani, J., Siraj, R., Naser, A., Alghamdi, A., Majrshi, M., Alghamdi, S., Alyami, M., et al. (2024) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s442851 · Cited by 15
Alsayed, A. R., Abed, A., Khader, H. A., Hasoun, L., Al Maqbali, M., & Al Shawabkeh, M. J. (2024) · Libyan Journal of Medicine · doi:10.1080/19932820.2024.2307679 · Cited by 12
Metadata
- Authors
- Elshafei, A., Safi, I., Aljoaid, A., Alanazi, O., & Almahd, S.
- Affiliations
- Department of Respiratory Therapy, College of Health Sciences, University of Doha for Science and Technology, Doha P.O. Box 24449, Qatar
- Department of Nursing, College of Health Sciences, University of Doha for Science and Technology, Doha P.O. Box 24449, Qatar
- Corresponding author
- Elshafei, Ahmad
- Venue
- Healthcare
- Publisher
- MDPI AG
- Published
- 2026-07-02
- Volume
- 14
- Issue
- 13
- Pages
- 1962
- ISSN
- 2227-9032 (ISSN-L)
- PMC
- PMC13362153
- OpenAlex
- W7167091691
- Cited by
- 0
- References
- 16
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Healthcare (publishedVersion, cc-by)
- Preprints.org (submittedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Open Science Framework (public-domain)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- chronic obstructive pulmonary disease, Gulf Cooperation Council, acute care utilization, medication adherence, hospitalization, emergency department visits, comorbidities, obesity, COPD exacerbations, healthcare burden
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review. https://app.cochat.ai/papers/10.3390/healthcare14131962
- The paper
- Elshafei, A., Safi, I., Aljoaid, A., Alanazi, O., & Almahd, S. (2026). Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review. Healthcare. https://doi.org/10.3390/healthcare14131962
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.